Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma

International Journal of Pharmaceutics

Volumn 445, Issue 1-2, 2013, Pages 79-87

  Bai, Cheng Zhe ^a   Choi, Sunghyun ^a   Nam, Kihoon ^b   An, Songhie ^a   Park, Jong Sang ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Apoptosis; Gene delivery; Interferon beta; Malignant glioma; PAMAM R

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ARGININE; CASPASE 3; DENDRIMER; DNA NUCLEOTIDYLEXOTRANSFERASE; EOSIN; HEMATOXYLIN; POLYAMIDOAMINE; RECOMBINANT BETA INTERFERON; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; GENE TARGETING; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; ARGININE; BRAIN NEOPLASMS; CASPASE 3; CELL LINE; CELL LINE, TUMOR; DENDRIMERS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GLIOMA; HUMANS; INTERFERON-BETA; MICE; MICE, NUDE; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874124218     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.057     Document Type: Article

References (33)

1. J. Baselga, L. Norton, J. Albanell, Y.M. Kim, and J. Mendelsohn Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts Cancer Res. 58 1998 2825 2831
2. N. Benachour, and G.E. Seralini Glyphosate formulations induce apoptosis and necrosis in human umbilical, embryonic, and placental cells Chem. Res. Toxicol. 22 2009 97 105
3. M.A. Bulbul, R.P. Huben, and G.P. Murphy Interferon-beta treatment of metastatic prostate cancer J. Surg. Oncol. 33 1986 231 233
4. H. Chen, J. Dong, and Q. Huang Xenograft model of human brain tumor, brain-tumors A.L. Dr. Abujamara, Current and Emerging Therapeutics Strategies 2011 InTech 978-953-307-588-4 http://www.intechopen.com/books/brain-tumors- current-and-emerging-therapeuticstrategies/xenograft-model-of-human-brain-tumor
5. J.S. Choi, K. Nam, J.Y. Park, J.B. Kim, J.K. Lee, and J.S. Park Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginine J. Control. Release 99 2004 445 456
6. F. Ciardiello, and G. Tortora A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor Clin. Cancer Res. 7 2001 2958 2970
7. F. Ciardiello, and G. Tortora Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs Eur. J. Cancer 39 2003 1348 1354
8. L.A. Edwards, J. Woo, L.A. Huxham, M. Verreault, W.H. Dragowska, G. Chiu, A. Rajput, A.H. Kyle, J. Kalra, D. Yapp, H. Yan, A.I. Minchinton, D. Huntsman, T. Daynard, D.N. Waterhouse, B. Thiessen, S. Dedhar, and M.B. Bally Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK) Mol Cancer Ther 7 2008 59 70
9. O. Engebraaten, G.O. Hjortland, S. Juell, H. Hirschberg, and O. Fodstad Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals Int. J. Cancer 97 2002 846 852
10. E.I. Fomchenko, and E.C. Holland Mouse models of brain tumors and their applications in preclinical trials Clin. Cancer Res. 12 2006 5288 5297
11. S.H. Juang, S.J. Wei, Y.M. Hung, C.Y. Hsu, D.M. Yang, K.J. Liu, W.S. Chen, and W.K. Yang IFN-beta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines J Interf Cytok Res 24 2004 231 243
12. S.J. Kang, S. Wang, H. Hara, E.P. Peterson, S. Namura, S. Amin-Hanjani, Z. Huang, A. Srinivasan, K.J. Tomaselli, N.A. Thornberry, M.A. Moskowitz, and J. Yuan Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions J. Cell Biol. 149 2000 613 622
13. H.S. Kim, and M.S. Lee STAT1 as a key modulator of cell death Cell. Signal. 19 2007 454 465
14. J.B. Kim, J.S. Choi, K. Nam, M. Lee, J.S. Park, and J.K. Lee Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg J. Control. Release 114 2006 110 117
15. M. Kim, Y. Yan, K. Lee, M. Sgagias, and K.H. Cowan Ectopic expression of von Hippel-Lindau tumor suppressor induces apoptosis in 786-O renal cell carcinoma cells and regresses tumor growth of 786-O cells in nude mouse Biochem. Biophys. Res. Commun. 320 2004 945 950
16. D. Klatzmann, C.A. Valery, G. Bensimon, B. Marro, O. Boyer, K. Mokhtari, B. Diquet, J.L. Salzmann, and J. Philippon A phase I/II study of herpes simplex virus type 1 thymidine kinase suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma Hum. Gene Ther. 9 1998 2595 2604
17. P.Y. Lam, and X.O. Breakefield Potential of gene therapy for brain tumors Hum. Mol. Genet. 10 2001 777 787
18. F.F. Lang, J.M. Bruner, G.N. Fuller, K. Aldape, M.D. Prados, S. Chang, M.S. Berger, M.W. McDermott, S.M. Kunwar, L.R. Junck, W. Chandler, J.A. Zwiebel, R.S. Kaplan, and W.K. Yung Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results J. Clin. Oncol. 21 2003 2508 2518
19. S.E. Lawler, P.P. Peruzzi, and E.A. Chiocca Genetic strategies for brain tumor therapy Cancer Gene Ther. 13 2006 225 233
20. R. LeBlanc, L.P. Catley, T. Hideshima, S. Lentzsch, C.S. Mitsiades, N. Mitsiades, D. Neuberg, O. Goloubeva, C.S. Pien, J. Adams, D. Gupta, P.G. Richardson, N.C. Munshi, and K.C. Anderson Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model Cancer Res. 62 2002 4996 5000
21. C.A. Maguire, D.H. Meijer, S.G. LeRoy, L.A. Tierney, M.L. Broekman, F.F. Costa, X.O. Breakefield, A. Stemmer-Rachamimov, and M. Sena-Esteves Preventing growth of brain tumors by creating a zone of resistance Mol. Ther. 16 2008 1695 1702
22. F. Martinon, and J. Tschopp Inflammatory caspases and inflammasomes: master switches of inflammation Cell Death Differ. 14 2007 10 22
23. J. Mendelsohn The epidermal growth factor receptor as a target for cancer therapy Endocrine-related cancer 8 2001 3 9
24. S. Nagata Apoptotic DNA fragmentation Exp. Cell Res. 256 2000 12 18
25. K.J. Pulkkanen, and S. Yla-Herttuala Gene therapy for malignant glioma: current clinical status Mol. Ther. 12 2005 585 598
26. X.Q. Qin, N. Tao, A. Dergay, P. Moy, S. Fawell, A. Davis, J.M. Wilson, and J. Barsoum Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice Proc. Natl. Acad. Sci. U.S.A. 95 1998 14411 14416
27. A. Richmond, and Y. Su Mouse xenograft models vs GEM models for human cancer therapeutics Dis. Models Mech. 1 2008 78 82
28. S. Sathornsumetee, and J.N. Rich New treatment strategies for malignant gliomas Expert Rev. Anticancer Ther. 6 2006 1087 1104
29. S.R. Schwarze, A. Ho, A. Vocero-Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1999 1569 1572
30. C.H. Tung, and R. Weissleder Arginine containing peptides as delivery vectors Adv. Drug Deliv. Rev. 55 2003 281 294
31. D. Vinatier, P. Dufour, and D. Subtil Apoptosis: a programmed cell death involved in ovarian and uterine physiology Eur. J. Obstet. Gynecol. Reprod. Biol. 67 1996 85 102
32. Y. Wang, L. He, G. He, Y. Kong, X. Liu, H. Cai, X. Liu, and W. Tan Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft Sheng Wu Gong Cheng Xue Bao 26 2010 780 788
33. J. Yoshida, M. Mizuno, and T. Wakabayashi Interferon-beta gene therapy for cancer: basic research to clinical application Cancer Sci. 95 2004 858 865